From: Homoharringtonine and omacetaxine for myeloid hematological malignancies
Reference
Rigemen (NO.)
Infection (%)
Damage of liver function (%)
Cardiotoxicity (%)
Yang 2005 [61]
DA(34)
44.4
13.9
8.8
HA(22)
36.4
0
Yuan 2011 [72]
DNR + ATRA(61)
67.2
14.8
HTT + ATRA(54)
57.4
18.5
1.9